Sfoglia per AUTORE
GIORDA CB
Collezione ASL Torino 3

  

Items : 20

Hospitalisation for herpes zoster in people with and without diabetes: A 10-year-observational study. in Diabetes research and clinical practice / Diabetes Res Clin Pract. 2024 Apr;210:111603. doi: 10.1016/j.diabres.2024.111603. Epub 2024 Mar 8.

2024
ASL Torino 5
ASL Torino 3

Gnavi R; Costa G; Romeo F; Picariello R; Tartaglino B; Nada E; Giorda CB;

An update on the incidence of type 1 diabetes during the COVID-19 pandemic years. in Diabetes, obesity & metabolism / Diabetes Obes Metab. 2023 Oct;25(10):3068-3070. doi: 10.1111/dom.15182. Epub 2023 Jul 3.

2023
ASL Torino 3
ASL Torino 5

Giorda CB; Gnavi R; Tartaglino B; Favella L; Romeo F; Rabbone I; Migliardi A; Ferro S;

Correction to: Increased incidence of type 1 diabetes in 2 years of COVID?19 pandemic. in Acta diabetologica / Acta Diabetol. 2023 May;60(5):719. doi: 10.1007/s00592-023-02072-5.

2023
ASL Torino 3
ASL Torino 5

Rabbone I; Migliardi A; Favella L; Manti R; Tartaglino B; Gnavi R; Giorda CB; Ferro S;

Hepatocellular carcinoma in a large cohort of type 2 diabetes patients. in Diabetes research and clinical practice / Diabetes Res Clin Pract. 2023 Jun;200:110684. doi: 10.1016/j.diabres.2023.110684. Epub 2023 Apr 24.

2023
ASL Torino 3
ASL Torino 5

Monge L; Gnavi R; Manti R; Nada E; Costa G; Tartaglino B; Giorda CB; Picariello R;

Increased incidence of type 1 diabetes in 2 years of COVID-19 pandemic. in Acta diabetologica / Acta Diabetol. 2023 Apr;60(4):587-589. doi: 10.1007/s00592-022-01986-w. Epub 2022 Dec 17.

2023
ASL Torino 5
ASL Torino 3

Rabbone I; Ferro S; Favella L; Migliardi A; Manti R; Tartaglino B; Giorda CB; Gnavi R;

Correction to: Increased incidence of type 1 diabetes in 2 years of COVID?19 pandemic (Acta Diabetologica, (2022), 60, 4, (587-589), 10.1007/s00592-022-01986-w) in Acta Diabetologica

2023
ASL Torino 3

Giorda CB; Gnavi R; Tartaglino B; Manti R; Migliardi A; Favella L; Ferro S; Rabbone I;

Instructive lessons from the analysis of assistance in diabetes during the first phase of COVID-19 pandemic. in Acta diabetologica / Acta Diabetol. 2022 Jun;59(6):861-864. doi: 10.1007/s00592-022-01855-6. Epub 2022 Feb 19.

2022
ASL Torino 4
ASL Torino 5
ASL Torino 3

Gnavi R; Romeo F; Doglio M; Nada E; Landriscina T; Giorda CB; Picariello R; Tartaglino B;

Hepatic fibrosis of any origin in a large population of type 2 diabetes patients. in Nutrition, metabolism, and cardiovascular diseases : NMCD / Nutr Metab Cardiovasc Dis. 2021 Sep 22;31(10):2887-2894. doi: 10.1016/j.numecd.2021.06.020. Epub 202

2021
ASL Torino 5
ASL Torino 3

Romeo F; Costa G; Giorda CB; Linzalata C; Nada E; Tartaglino B; Picariello R; Gnavi R;

From swab testing to health outcomes within the T2DM population: Impact of diabetes background on COVID19 progression. in Diabetes research and clinical practice / Diabetes Res Clin Pract. 2021 Oct;180:109021. doi: 10.1016/j.diabres.2021.109021. Epub 2021 Aug 23.

2021
ASL Torino 5
ASL Torino 3

Gnavi R; Romeo F; Costa G; Doglio M; Nada E; Tartaglino B; Picariello R; Giorda CB;

Incidence of hospitalization and mortality in patients with diabetic foot regardless of amputation: a population study. in Acta diabetologica / Acta Diabetol. 2020 Feb;57(2):221-228. doi: 10.1007/s00592-019-01412-8. Epub 2019 Aug 29.

2020
ASL Torino 5
AOU Città della Salute di Torino
ASL Torino 3

Boffano GM; Giorda CB; Broglio F; Carnà P; Monge L; Gnavi R;

Incretin-based therapy and risk of cholangiocarcinoma: a nested case-control study in a population of subjects with type 2 diabetes. in Acta diabetologica / Acta Diabetol. 2020 Apr;57(4):401-408. doi: 10.1007/s00592-019-01444-0. Epub 2019 Nov 5.

2020
ASL Torino 5
ASL Torino 3

Nada E; Gnavi R; Costa G; Tartaglino B; Picariello R; Giorda CB;

Impact of severe and symptomatic hypoglycemia on quality of life and fear of hypoglycemia in type 1 and type 2 diabetes. Results of the Hypos-1 observational study. in Nutrition, metabolism, and cardiovascular diseases : NMCD / Nutr Metab Cardiovasc Dis. 2019 Jul;29(7):736-743. doi: 10.1016/j.numecd.2019.04.009. Epub 2019 May

2019
ASL Torino 5
ASL Torino 4
ASL Torino 3

Lucisano G; Giorda CB; Romeo F; Baccetti F; Gentile FM; Rossi MC; Nicolucci A; Chiambretti A; Aglialoro A; Gentile S; Ozzello A;

Ten-year comparative analysis of incidence, prognosis, and associated factors for dialysis and renal transplantation in type 1 and type 2 diabetes versus non-diabetes. in Acta diabetologica / Acta Diabetol. 2018 Jul;55(7):733-740. doi: 10.1007/s00592-018-1142-y. Epub 2018 Apr 20.

2018
ASL Torino 5
ASL Torino 3

Gnavi R; Giorda CB; Tartaglino B; Costa G; Picariello R; Salomone M; Carnà P;

Healthcare resource use, direct and indirect costs of hypoglycemia in type 1 and type 2 diabetes, and nationwide projections. Results of the HYPOS-1 study. in Nutrition, metabolism, and cardiovascular diseases : NMCD / Nutr Metab Cardiovasc Dis. 2017 Mar;27(3):209-216. doi: 10.1016/j.numecd.2016.10.005. Epub 2016 Nov

2017
ASL Torino 5
ASL Torino 4
ASL Torino 3

Romeo F; Lucisano G; Nicolucci A; Baccetti F; Gentile FM; Chiambretti A; Aglialoro A; Giorda CB; Gentile S; Ozzello O; Rossi MC;

Incidence and risk factors for severe and symptomatic hypoglycemia in type 1 diabetes. Results of the HYPOS-1 study. in Acta diabetologica / Acta Diabetol. 2015 Oct;52(5):845-53. doi: 10.1007/s00592-015-0713-4. Epub 2015 Feb 12.

2015
ASL Torino 5
ASL Torino 4
ASL Torino 3

Rossi MC; Nicolucci A; Lucisano G; Chiambretti A; Baccetti F; Gentile FM; Gentile S; Aglialoro A; Ozzello A; Giorda CB;

Incretin-based therapies and acute pancreatitis risk: a systematic review and meta-analysis of observational studies. in Endocrine / Endocrine. 2015 Mar;48(2):461-71. doi: 10.1007/s12020-014-0386-8. Epub 2014 Aug 22.

2015
ASL Torino 5
ASL Torino 3

Gnavi R; Baldi I; Marafetti L; Sacerdote C; Nada E; Giorda CB;

Hospitalisation for heart failure and mortality associated with dipeptidyl peptidase 4 (DPP-4) inhibitor use in an unselected population of subjects with type 2 diabetes: a nested case-control study. in BMJ open / BMJ Open. 2015 Jun 5;5(6):e007959. doi: 10.1136/bmjopen-2015-007959.

2015
ASL Torino 5
ASL Torino 3

Gnavi R; Di Noi F; Picariello R; Alessiato A; Marafetti L; Tartaglino B; Costa G; Giorda CB;

A systematic review of acute pancreatitis as an adverse event of type 2 diabetes drugs: from hard facts to a balanced position. in Diabetes, obesity & metabolism / Diabetes Obes Metab. 2014 Nov;16(11):1041-7. doi: 10.1111/dom.12297. Epub 2014 Apr 29.

2014
ASL Torino 5
ASL Torino 3

Marafetti L; Tartaglino B; Nada E; Gnavi R; Giorda CB;

Comparison of direct costs of type 2 diabetes care: different care models with different outcomes. in Nutrition, metabolism, and cardiovascular diseases : NMCD / Nutr Metab Cardiovasc Dis. 2014 Jul;24(7):717-24. doi: 10.1016/j.numecd.2014.01.009. Epub 2014 Jan 2

2014
ASL Torino 5
ASL Torino 3

Costa G; Gnavi R; Petrelli A; Marafetti L; Picariello R; Tartaglino B; Nada E; Giorda CB;

Incretin therapies and risk of hospital admission for acute pancreatitis in an unselected population of European patients with type 2 diabetes: a case-control study. in The lancet. Diabetes & endocrinology / Lancet Diabetes Endocrinol. 2014 Feb;2(2):111-5. doi: 10.1016/S2213-8587(13)70147-5. Epub 2013 Nov 1

2014
ASL Torino 5
ASL Torino 3

Gnavi R; Marafetti L; Costa G; Tartaglino B; Giorda CB; Nada E; Picariello R;